The right biomarker, measured the right way — from discovery to the clinic.
CLIA-certified, GLP-compliant biomarker analysis across 11 platforms and 150+ biomarkers. We choose the best analytical pathway for your program, then develop, qualify, and validate the assay — not just run the newest instrument.
- 150+
- Biomarkers
- 11
- Platforms
- 40+
- Companies in 2024
- CLIA
- Certified & GLP
Talk to a biomarker scientist
Tell us your indication. A scientist replies within one business day.
No spam. Your details go straight to our scientific team.
Trusted by 300+ biotechnology & pharmaceutical companies
-1.png?width=1041&height=849&name=Untitled%20design%20(29)-1.png)
Sound familiar?
How it works
Through our sister lab SBH Diagnostics, we deliver biomarker strategy and analysis end-to-end — identifying the right marker, choosing the platform, and validating a fit-for-purpose assay.
1 · Identify the biomarker
We help select the biomarker that best reflects target engagement, pharmacodynamics, or patient response for your program.
2 · Choose the platform
From 11 platforms, we pick the best analytical pathway — not a one-size-fits-all instrument — to fit your sample type and sensitivity needs.
3 · Develop, qualify, validate
We develop and validate a fit-for-purpose assay, moving from research-grade through CLIA/GLP as your program advances.
4 · Run clinical samples
We process clinical-trial samples with accessioning, chain-of-custody, storage, biobanking, and PK/PD analysis.
The specifics
The hard facts scientists ask for before they commit.
- Biomarkers
- 150+ available
- Platforms
- 11 (ELISA, Luminex, MSD, WES…)
- Compliance
- CLIA-certified, GLP-compliant
- Samples
- Serum, plasma, blood, urine, CSF, tissue
- Stage
- Discovery → Phase I–III → CDx
- Multiplex
- Up to 50 analytes at once
What you get
Every engagement delivers:
- A fit-for-purpose, validated biomarker assay
- CLIA/GLP-grade data ready for regulators
- One lab from discovery through companion diagnostic
- Proper handling of clinical samples end-to-end
- Guidance on the right marker and platform
Clinical-grade, trusted at scale
In 2024 alone, our scientists provided biomarker analysis and diagnostic support to over 40 companies — from early discovery through clinical validation.
Frequently asked questions
Are you CLIA-certified?
Yes — clinical biomarker testing is delivered through SBH Diagnostics, a CLIA-certified, GLP-compliant laboratory.
Can you develop a custom assay?
Yes. When no kit exists for your biomarker, we build custom panels and validate assays for your program.
Do you handle clinical-trial samples?
Yes — including accessioning, chain-of-custody documentation, storage, biobanking, and PK/PD analysis.
Which sample types can you run?
Serum, plasma, whole blood, urine, tissue, PBMCs, CSF, and cell-culture supernatants, from humans or animals.
Ready to move your program forward?
Get a fast, no-obligation quote from our scientific team — or explore the full range of SBH Sciences services.